Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...
Abbott has announced the company has received approval from the U.S. Food and Drug Administration (FDA) for its Volt PFA ...
TipRanks on MSN
Boston Scientific’s global pulsed field ablation trial targets persistent atrial fibrillation growth
Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study OverviewThis global Boston Scientific trial, officially titled ...
US FDA approves Abbott's Volt PFA System to treat patients with atrial fibrillation: Abbott Park, Illinois Wednesday, December 24, 2025, 12:00 Hrs [IST] Abbott, is a global health ...
5d
Pulse Biosciences (PLSE): Valuation Check After FDA IDE Approval for nPulse Cardiac Ablation Trial
Pulse Biosciences (PLSE) just cleared a key regulatory hurdle, with the FDA signing off on its Investigational Device Exemption for the nPulse Cardiac Catheter Ablation System in atrial fibrillation, ...
Zacks Investment Research on MSN
PLSE wins FDA IDE approval to launch nPulse AF ablation study trial
Pulse Biosciences PLSE recently announced that the FDA has granted Investigational Device Exemption (“IDE”) approval to ...
Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.
Medtronic has secured the first FDA green light for a pulsed field ablation system, bringing a new type of atrial fibrillation treatment to the U.S. By using short bursts of specifically tuned ...
Catheter ablation significantly reduces cardiovascular risks and mortality in patients with both atrial fibrillation and obstructive sleep apnea. The study involved over 18,000 patients, showing a ...
Convergent hybrid ablation is an innovative treatment for a type of irregular heart rhythm called atrial fibrillation (AFib). The treatment is a two-stage procedure that combines the expertise of our ...
A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons, finds that Medicare patients with atrial fibrillation (AF) who undergo surgical ablation ...
DALLAS, Oct. 10, 2024 — Three common cardiovascular diseases in adults—heart failure, atrial fibrillation and coronary heart disease—are linked to cognitive impairment and increased risk of dementia, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback